Showing results (1941-1950 of 1,985) with videos related to

Sort By:
Pageof 199
The Lancet. Neurology|June 14, 2024
Safety and efficacy of stent retrievers plus contact aspiration in patients with acute ischaemic anterior circulation stroke and positive susceptibility vessel sign in France (VECTOR): a randomised, single-blind trialRomain Bourcier, Gaultier Marnat, Cyril Dargazanli, et al.
The Lancet. Neurology|November 17, 2023
Safety and efficacy of gene replacement therapy for X-linked myotubular myopathy (ASPIRO): a multinational, open-label, dose-escalation trialPerry B Shieh, Nancy L Kuntz, James J Dowling, et al.
The Lancet. Neurology|October 20, 2023
Stimulation of TREM2 with agonistic antibodies-an emerging therapeutic option for Alzheimer's diseaseKai Schlepckow, Estrella Morenas-Rodríguez, Soyon Hong, et al.
The Lancet. Neurology|October 20, 2023
Effect of blood pressure-lowering agents on microvascular function in people with small vessel diseases (TREAT-SVDs): a multicentre, open-label, randomised, crossover trialAnna Kopczak, Michael S Stringer, Hilde van den Brink, et al.
The Lancet. Neurology|April 13, 2024
RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analysesEmil K Gustavsson, Jordan Follett, Joanne Trinh, et al.
The Lancet. Neurology|September 17, 2023
Migraine in older adultsSarah Sonja Hugger, Thien Phu Do, Håkan Ashina, et al.
The Lancet. Neurology|August 18, 2023
The assessment of dysphagia after stroke: state of the art and future directionsBendix Labeit, Emilia Michou, Shaheen Hamdy, et al.
The Lancet. Neurology|January 24, 2024
Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysisMarianne Chapleau, Renaud La Joie, Keir Yong, et al.
The Lancet. Neurology|January 24, 2024
Challenges and opportunities in spinal muscular atrophy therapeuticsCrystal J J Yeo, Eduardo F Tizzano, Basil T Darras
The Lancet. Neurology|December 15, 2023
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP): a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trialMukul Sharma, Carlos A Molina, Kazunori Toyoda, et al.
Pageof 199